| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Over the last 12 months, insiders at Aptevo Therapeutics Inc. have bought $0 and sold $0 worth of Aptevo Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Aptevo Therapeutics Inc. have bought $49.69M and sold $16.87M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 348,554 shares for transaction amount of $7.92M was made by TANG KEVIN C (10 percent owner) on 2020‑11‑06.
| 2021-11-23 | Sale | TANG KEVIN C | 921,336 12.987% | $11.25 | $10.37M | -73.69% | ||
| 2021-11-22 | Sale | TANG KEVIN C | 10 percent owner | 255,331 5.9122% | $7.03 | $1.8M | -30.86% | |
| 2021-11-19 | Sale | TANG KEVIN C | 10 percent owner | 213,800 4.7422% | $7.59 | $1.62M | -38.63% | |
| 2021-11-18 | Sale | TANG KEVIN C | 10 percent owner | 369,533 8.1153% | $8.34 | $3.08M | -44.69% | |
| 2020-11-06 | TANG KEVIN C | 10 percent owner | 348,554 7.5668% | $22.73 | $7.92M | +8.23% | ||
| 2020-11-05 | TANG KEVIN C | 10 percent owner | 1.25M 25.0765% | $18.78 | $23.5M | +20.82% | ||
| 2020-11-04 | TANG KEVIN C | 10 percent owner | 1.27M 24.3464% | $14.34 | $18.27M | +50.91% | ||
| 2019-08-16 | Maddux Randy Joe | SVP Operations, CMO | 50,000 0.1097% | $0.76 | $38,000 | -25.67% | ||
| 2019-08-12 | El-Hibri Fuad | director | 200,000 0.4342% | $0.76 | $151,040 | -25.24% | ||
| 2019-07-29 | El-Hibri Fuad | Board of Directors | 110,030 0.2409% | $0.83 | $91,721 | -31.45% | ||
| 2019-07-23 | El-Hibri Fuad | Board of Directors | 20,000 0.0452% | $0.90 | $17,992 | -34.35% | ||
| 2019-07-22 | El-Hibri Fuad | Board of Directors | 60,000 0.1331% | $0.89 | $53,202 | -34.06% | ||
| 2019-07-19 | El-Hibri Fuad | Board of Directors | 52,920 0.1212% | $0.90 | $47,480 | -33.33% | ||
| 2019-07-18 | El-Hibri Fuad | Board of Directors | 28,808 0.0638% | $0.87 | $25,193 | -33.40% | ||
| 2019-07-17 | El-Hibri Fuad | Board of Directors | 38,272 0.085% | $0.87 | $33,408 | -32.68% | ||
| 2019-07-16 | El-Hibri Fuad | Board of Directors | 22,750 0.0486% | $0.85 | $19,324 | -33.41% | ||
| 2019-07-11 | El-Hibri Fuad | Board of Directors | 29,382 0.0649% | $0.85 | $24,907 | -30.51% | ||
| 2019-07-10 | El-Hibri Fuad | director | 37,838 0.0843% | $0.85 | $32,117 | -30.01% | ||
| 2019-06-25 | Abdun-Nabi Daniel | Board of Directors | 33,334 0.0753% | $0.90 | $30,001 | -33.16% | ||
| 2019-06-14 | White Marvin L | President and CEO | 100,000 0.2219% | $0.88 | $88,000 | -30.63% |
| Increased Positions | 5 | +29.41% | 18,379 | +37.87% |
| Decreased Positions | 8 | -47.06% | 47,285 | -97.42% |
| New Positions | 2 | New | 13,326 | New |
| Sold Out Positions | 6 | Sold Out | 43,318 | Sold Out |
| Total Postitions | 14 | -17.65% | 19,629 | -59.56% |
| Virtu Financial Llc | $11.00 | 0.36% | 21,627 | +20,493 | +1,807.14% | 2024-12-31 |
| Hrt Financial Lp | $6.00 | 0.21% | 12,324 | +11,564 | +1,521.58% | 2024-12-31 |
| Jpmorgan Chase & Co | $2.00 | 0.08% | 4,529 | +4,528 | +452,800% | 2024-12-31 |
| Diadema Partners Lp | $2.00 | 0.07% | 4,050 | +4,050 | New | 2024-12-31 |
| Morgan Stanley | $2.00 | 0.07% | 3,927 | +3,922 | +78,440% | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.02% | 1,086 | +408 | +60.18% | 2024-12-31 |
| Ubs Group Ag | $0 | 0.01% | 783 | +783 | New | 2024-12-31 |
| Sbi Securities Co., Ltd. | $0 | 0.01% | 701 | +570 | +435.12% | 2025-03-31 |
| Osaic Holdings, Inc. | $0 | <0.01% | 45 | +44 | +4,400% | 2024-12-31 |
| Blackrock, Inc. | $0 | 0% | 24 | 0 | 0% | 2025-03-31 |